﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropharmacology</JournalTitle>
      <Issn>2345-4202</Issn>
      <Volume>16</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2027</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Recurrent dehydration and chronic kidney disease; molecular pathways linking osmotic stress, tubular injury and fibrotic progression</ArticleTitle>
    <FirstPage>e12894</FirstPage>
    <LastPage>e12894</LastPage>
    <ELocationID EIdType="doi">10.34172/npj.12894</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Eleonora</FirstName>
        <LastName>Tashkenbaeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5705-4972</Identifier>
      </Author>
      <Author>
        <FirstName>Maftuna</FirstName>
        <LastName>Abdulloeva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0002-0911-0890</Identifier>
      </Author>
      <Author>
        <FirstName>Iroda</FirstName>
        <LastName>Salieva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-6358-519X</Identifier>
      </Author>
      <Author>
        <FirstName>Sabokhat</FirstName>
        <LastName>Tuychieva</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0005-0889-7320</Identifier>
      </Author>
      <Author>
        <FirstName>Laziz</FirstName>
        <LastName>Yorbulov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0009-8721-2199</Identifier>
      </Author>
      <Author>
        <FirstName>Sadriddin</FirstName>
        <LastName>Mukhtarov</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0000-2511-4133</Identifier>
      </Author>
      <Author>
        <FirstName>Farida</FirstName>
        <LastName>Khasanjanova</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0006-5049-6333</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/npj.12894</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>04</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract>Recurrent dehydration has detected as a significant, modifiable risk factor for the development and progression of chronic kidney disease, particularly in populations exposed to occupational heat stress or limited fluid access. This overview sought to consider current findings on the molecular pathways linking episodic volume depletion to sustained renal dysfunction, emphasizing osmotic stress as the primary catalyst for tubular epithelial injury. Repeated hyperosmolar insults disrupt cellular homeostasis, provoking mitochondrial dysfunction, endoplasmic reticulum stress, and excessive reactive oxygen species production. These perturbations activate conserved signaling cascades, notably p38 MAPK, NF-κB, and the NLRP3 inflammasome, which drive pro-inflammatory cytokine release and sustained leukocyte infiltration. Concurrently, osmotic stress potently upregulates transforming growth factor-beta and connective tissue growth factor, precipitating epithelial-to-mesenchymal transition and myofibroblast differentiation. The consequent extracellular matrix accumulation, compounded by defective autophagy and maladaptive proliferative responses, establishes a self-sustaining loop of tubulointerstitial fibrosis. Recurrent dehydration further amplifies intrarenal renin-angiotensin-aldosterone system activity and endothelin-1 signaling, accelerating peritubular capillary loss and hypoxia-driven fibrogenesis. Recent data further implicate urea transporter dysregulation and tonicity-responsive enhancer-binding protein activation in exacerbating tubular cell cycle arrest and cellular senescence. Interpretation of these interconnected molecular networks reveals promising therapeutic targets that could interrupt the transition from acute osmotic injury to irreversible architectural damage. Finally, integrating mechanistic insights with clinical epidemiology reinforces the urgent need for evidence-based hydration protocols and novel antifibrotic strategies to mitigate the rising global incidence of dehydration-related chronic kidney disease. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Dehydration</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Acute kidney injury</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic kidney disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Fibrosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Reactive oxygen species</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>